US04280AAC45 · Corp · USD

Arrowhead Pharmaceuticals Inc 0.00% 2032/01

MID PRICE
113.93
par = 100
YIELD TO MAT.
0.00%
semi-annual
COUPON
0.000%
semi-annual · fixed
MATURITY
2032-01-15
bullet · 5.70y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
5.70 y
1bp ↑ ≈ -0.057% P&L
Convexity
35.38
higher = more curvature
Years to maturity
5.70 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Convertible Bond
iShares
US Convertibles$14.3M▲ $253K0.24%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

15/ 100Minimal footprint
Interpretation. Minimal institutional footprint, holding
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$14.3M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▼ $134K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
113,930 USD
PRICE
113.93

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
ARWR 0 01/15/32
FIGI
BBG01ZG5ZZ15
CUSIP
04280AAC4
ISIN
US04280AAC45
Type
Corp
Issued
2026-01-12
Face value
100 USD
Ticker
ARWR 0 01/15/32
Sec. type
GLOBAL
Seniority
Senior Unsecured